Does Adenosine Interact with Asprin And Extended Release Dipyridamole?
CDI records a major classification for Adenosine and Asprin And Extended Release Dipyridamole. The stored summary is: Dipyridamole increases plasma levels and cardiovascular effects of adenosine. Adjustment of adenosine dosage may be necessary. The mechanism involves dipyridamole increases adenosine plasma levels and cardiovascular effects. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Major
- Adenosine Class
- Adenosine Receptor Agonist
- Asprin And Extended Release Dipyridamole Class
- Nonsteroidal Anti-inflammatory Drug
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Dipyridamole increases adenosine plasma levels and cardiovascular effects
What To Tell Your Doctor or Pharmacist
If you are taking Adenosine and your doctor is considering prescribing Asprin And Extended Release Dipyridamole (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider